POLICY UPDATES: This disclaimer may be updated at any time without notice
The Retatrutide vs Tirzepatide question will continue to evolve as Phase 3 results emerge and regulatory decisions are made in the coming years
DOria R, Schipani R, Leonardini A, Natalicchio A, Perrini S, Cignarelli A, et al
Ipamorelin side effects may include injection-site irritation, headache, dizziness, fatigue, appetite changes, mild water retention, or joint discomfort
CJC-1295 + Ipamorelin combines a longer-acting GHRH analog with a selective GHS-R1a agonist, engaging two distinct receptor pathways